Economic Impact of Biosimilars: Reducing Healthcare Costs Without Compromising Quality
Inflation in healthcare costs is a global concern, and biological medicines are a primary contributor to this trend. While these drugs offer revolutionary treatments for complex diseases, their high prices put a strain on insurance providers and national health budgets. Biosimilars offer a viable solution by introducing price competition into a sector that was once dominated by monopolies. The...
0 Commentarios 0 Acciones 67 Views 0 Vista previa